PerpEquities

Equity · Healthcare

Is Medtronic (MDT) tradable as a perp? Not yet

Medtronic develops and sells medical devices across cardiovascular, surgical, neuroscience, and diabetes care portfolios.

Not yet listed on any perp exchange

No perpetual-futures venue lists MDT yet. We track it continuously; as soon as the first listing appears, this page becomes a full market page. Until then: fundamentals below and tradable alternatives.

Similar stocks already tradable as perps
VRTXISRGREGNPFEBSXMRNA

Price chart

Interactive TradingView chart

TradingView symbol NYSE:MDT

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Company data

Company fundamentals

Updated 1h ago
Market cap
$117.9B
Updated 1h ago
Revenue
$37.5B
Trailing 12 months
Revenue growth
+7%
Next fiscal year
Profit margin
+13.9%
P/E
22.5
Peer P/E 18.1
Free cash flow
$6.1B
Trailing 12 months
More metrics
Net income
$5.2B
Trailing 12 months
P/S
3.1
Peer P/E
18.1
Similar listed perps
Revenue estimate
$39.1B
Next fiscal year
Earnings
2026-11-17
Revenue est. $9.5B · Updated 1h ago
Dividend
$0.72
2026-09-25

Fundamental detail

Annual + quarterly
Latest revenue$36.4B
Net margin+13.2%
Free cash flow$5.4B
Net debt$26B
2021$30.1B
2022$31.7B
2023$31.2B
2024$32.4B
2025$33.5B
2026$36.4B
PeriodRevenueGrowthNet incomeFCF
2021$30.1B+4%$3.6B$4.9B
2022$31.7B+5%$5B$6B
2023$31.2B-1%$3.8B$4.6B
2024$32.4B+4%$3.7B$5.2B
2025$33.5B+4%$4.7B$5.2B
2026$36.4B+8%$4.8B$5.4B
PeriodGross marginOperating marginNet marginROEROA
2021+65.2%+14.9%+12.0%+7.0%+3.9%
2022+68.0%+18.2%+15.9%+9.6%+5.5%
2023+65.7%+17.6%+12.0%+7.3%+4.1%
2024+65.3%+15.9%+11.4%+7.3%+4.1%
2025+65.3%+17.8%+13.9%+9.7%+5.1%
2026+65.0%+17.8%+13.2%+9.7%+5.2%
PeriodCashDebtNet debtCurrent ratio
2021$3.6B$26.4B$22.8B2.65
2022$3.7B$24.1B$20.4B1.86
2023$1.5B$24.4B$22.8B2.39
2024$1.3B$25B$23.7B2.03
2025$2.2B$28.5B$26.3B1.85
2026$1.9B$28B$26B2.13
PeriodMarket capEnterprise valueP/SP/E
2021$176.1B$198.9B5.848.9
2022$140.1B$160.5B4.427.8
2023$120.9B$143.8B3.932.1
2024$105.9B$129.6B3.328.8
2025$108.2B$134.5B3.223.2
2026$106.8B$132.8B2.922.2
Q2 2025$8.4B
Q3 2025$8.3B
Q4 2025$8.9B
Q1 2026$8.6B
Q2 2026$9B
Q3 2026$9B
Q4 2026$9.8B
Q1 2027$9.8B
PeriodRevenueGrowthNet incomeFCF
Q2 2025$8.4B+5%$1.3B$554M
Q3 2025$8.3B+3%$1.3B$2.1B
Q4 2025$8.9B+4%$1.1B$2.1B
Q1 2026$8.6B+8%$1B$584M
Q2 2026$9B+7%$1.4B$457M
Q3 2026$9B+9%$1.1B$2.3B
Q4 2026$9.8B+10%$1.2B$2.1B
Q1 2027$9.8B+14%$1.5B$1.3B
PeriodGross marginOperating marginNet marginROEROA
Q2 2025+64.9%+19.0%+15.1%+2.6%+1.4%
Q3 2025+66.5%+19.9%+15.6%+2.6%+1.4%
Q4 2025+64.7%+16.1%+11.8%+2.2%+1.2%
Q1 2026+57.7%+16.8%+12.1%+2.2%+1.1%
Q2 2026+60.3%+18.8%+15.3%+2.8%+1.5%
Q3 2026+64.9%+19.7%+12.7%+2.3%+1.2%
Q4 2026+75.9%+15.9%+12.7%+2.5%+1.3%
Q1 2027+65.0%+18.1%+15.1%+2.9%+1.6%
PeriodCashDebtNet debtCurrent ratio
Q2 2025$1.4B$28.3B$26.9B1.84
Q3 2025$1.2B$26.6B$25.4B1.90
Q4 2025$2.2B$28.5B$26.3B1.85
Q1 2026$1.3B$28.6B$27.3B2.01
Q2 2026$1.3B$29.1B$27.8B2.42
Q3 2026$1.1B$28.1B$26.9B2.54
Q4 2026$1.9B$28B$26B2.13
Q1 2027$1.7B$28.2B$26.5B2.07
PeriodMarket capEnterprise valueP/SP/E
Q2 2025$116.2B$143.1B13.822.9
Q3 2025$115.7B$141B13.922.3
Q4 2025$107.9B$134.2B12.125.7
Q1 2026$119.1B$146.4B13.928.7
Q2 2026$120.1B$147.9B13.421.9
Q3 2026$129.3B$156.3B14.328.3
Q4 2026$106.8B$132.8B10.921.3
Q1 2027$109.3B$135.7B11.218.6

Refreshed 1h ago

Charts: revenue, profit, cash flow & valuation
Revenue$9.8BQ1 2027
$2.5B$4.9B$7.4B$9.8BQ2 2024: $8BQ3 2024: $8.1BQ4 2024: $8.6BQ1 2025: $7.9BQ2 2025: $8.4BQ3 2025: $8.3BQ4 2025: $8.9BQ1 2026: $8.6BQ2 2026: $9BQ3 2026: $9BQ4 2026: $9.8BQ1 2027: $9.8BQ2 2024Q1 2027
Net income$1.5BQ1 2027
$367.5M$735M$1.1B$1.5BQ2 2024: $909MQ3 2024: $1.3BQ4 2024: $654MQ1 2025: $1BQ2 2025: $1.3BQ3 2025: $1.3BQ4 2025: $1.1BQ1 2026: $1BQ2 2026: $1.4BQ3 2026: $1.1BQ4 2026: $1.2BQ1 2027: $1.5BQ2 2024Q1 2027
EBITDA$2BQ1 2027
$659.3M$1.3B$2B$2.6BQ2 2024: $2.2BQ3 2024: $2.3BQ4 2024: $1.7BQ1 2025: $2.1BQ2 2025: $2.4BQ3 2025: $2.4BQ4 2025: $2.3BQ1 2026: $2.2BQ2 2026: $2.4BQ3 2026: $2.5BQ4 2026: $2.6BQ1 2027: $2BQ2 2024Q1 2027
Free cash flow$1.3BQ1 2027
$587.8M$1.2B$1.8B$2.4BQ2 2024: $200MQ3 2024: $2.1BQ4 2024: $2.4BQ1 2025: $466MQ2 2025: $554MQ3 2025: $2.1BQ4 2025: $2.1BQ1 2026: $584MQ2 2026: $457MQ3 2026: $2.3BQ4 2026: $2.1BQ1 2027: $1.3BQ2 2024Q1 2027
EPS$1.14Q1 2027
$0.29$0.57$0.86$1.14Q2 2024: $0.68Q3 2024: $0.99Q4 2024: $0.49Q1 2025: $0.8Q2 2025: $0.99Q3 2025: $1.01Q4 2025: $0.82Q1 2026: $0.81Q2 2026: $1.07Q3 2026: $0.89Q4 2026: $0.96Q1 2027: $1.14Q2 2024Q1 2027
Cash / Debt$1.7BQ1 2027
$7.3B$14.6B$21.8B$29.1BQ2 2024 · Cash: $1.3BQ2 2024 · Debt: $25.1BQ3 2024 · Cash: $1.6BQ3 2024 · Debt: $25.2BQ4 2024 · Cash: $1.3BQ4 2024 · Debt: $25BQ1 2025 · Cash: $1.3BQ1 2025 · Debt: $27.9BQ2 2025 · Cash: $1.4BQ2 2025 · Debt: $28.3BQ3 2025 · Cash: $1.2BQ3 2025 · Debt: $26.6BQ4 2025 · Cash: $2.2BQ4 2025 · Debt: $28.5BQ1 2026 · Cash: $1.3BQ1 2026 · Debt: $28.6BQ2 2026 · Cash: $1.3BQ2 2026 · Debt: $29.1BQ3 2026 · Cash: $1.1BQ3 2026 · Debt: $28.1BQ4 2026 · Cash: $1.9BQ4 2026 · Debt: $28BQ1 2027 · Cash: $1.7BQ1 2027 · Debt: $28.2BQ2 2024Q1 2027
CashDebt
Profitability+65.0%Q1 2027
+19.0%+37.9%+56.9%+75.9%Q2 2024 · Gross margin: +65.4%Q3 2024 · Gross margin: +65.6%Q4 2024 · Gross margin: +64.6%Q1 2025 · Gross margin: +65.1%Q2 2025 · Gross margin: +64.9%Q3 2025 · Gross margin: +66.5%Q4 2025 · Gross margin: +64.7%Q1 2026 · Gross margin: +57.7%Q2 2026 · Gross margin: +60.3%Q3 2026 · Gross margin: +64.9%Q4 2026 · Gross margin: +75.9%Q1 2027 · Gross margin: +65.0%Q2 2024 · Operating margin: +16.8%Q3 2024 · Operating margin: +18.3%Q4 2024 · Operating margin: +12.3%Q1 2025 · Operating margin: +16.1%Q2 2025 · Operating margin: +19.0%Q3 2025 · Operating margin: +19.9%Q4 2025 · Operating margin: +16.1%Q1 2026 · Operating margin: +16.8%Q2 2026 · Operating margin: +18.8%Q3 2026 · Operating margin: +19.7%Q4 2026 · Operating margin: +15.9%Q1 2027 · Operating margin: +18.1%Q2 2024 · Net margin: +11.4%Q3 2024 · Net margin: +16.3%Q4 2024 · Net margin: +7.6%Q1 2025 · Net margin: +13.2%Q2 2025 · Net margin: +15.1%Q3 2025 · Net margin: +15.6%Q4 2025 · Net margin: +11.8%Q1 2026 · Net margin: +12.1%Q2 2026 · Net margin: +15.3%Q3 2026 · Net margin: +12.7%Q4 2026 · Net margin: +12.7%Q1 2027 · Net margin: +15.1%Q2 2024Q1 2027
Gross marginOperating marginNet margin
Revenue growth+13.7%Q1 2027
+3.4%+6.9%+10.3%+13.7%Q1 2025: +2.8%Q2 2025: +5.2%Q3 2025: +2.5%Q4 2025: +3.9%Q1 2026: +8.4%Q2 2026: +6.6%Q3 2026: +8.8%Q4 2026: +9.9%Q1 2027: +13.7%Q2 2024Q1 2027
Shares outstanding1.3BQ1 2027
333M666M998.9M1.3BQ2 2024: 1.3BQ3 2024: 1.3BQ4 2024: 1.3BQ1 2025: 1.3BQ2 2025: 1.3BQ3 2025: 1.3BQ4 2025: 1.3BQ1 2026: 1.3BQ2 2026: 1.3BQ3 2026: 1.3BQ4 2026: 1.3BQ1 2027: 1.3BQ2 2024Q1 2027
Valuation18.6Q1 2027
10.220.330.540.7Q2 2024 · P/E: 25.5Q3 2024 · P/E: 21.9Q4 2024 · P/E: 40.7Q1 2025 · P/E: 24.3Q2 2025 · P/E: 22.9Q3 2025 · P/E: 22.3Q4 2025 · P/E: 25.7Q1 2026 · P/E: 28.7Q2 2026 · P/E: 21.9Q3 2026 · P/E: 28.3Q4 2026 · P/E: 21.3Q1 2027 · P/E: 18.6Q2 2024 · P/S: 11.6Q3 2024 · P/S: 14.2Q4 2024 · P/S: 12.3Q1 2025 · P/S: 12.9Q2 2025 · P/S: 13.8Q3 2025 · P/S: 13.9Q4 2025 · P/S: 12.1Q1 2026 · P/S: 13.9Q2 2026 · P/S: 13.4Q3 2026 · P/S: 14.3Q4 2026 · P/S: 10.9Q1 2027 · P/S: 11.2Q2 2024Q1 2027
P/EP/S
Revenue$36.4B2026
$9.1B$18.2B$27.3B$36.4B2019: $30.6B2020: $28.9B2021: $30.1B2022: $31.7B2023: $31.2B2024: $32.4B2025: $33.5B2026: $36.4B20192026
Net income$4.8B2026
$1.3B$2.5B$3.8B$5B2019: $4.6B2020: $4.8B2021: $3.6B2022: $5B2023: $3.8B2024: $3.7B2025: $4.7B2026: $4.8B20192026
EBITDA$9.8B2026
$2.5B$4.9B$7.4B$9.8B2019: $9.3B2020: $7.8B2021: $7.5B2022: $8.8B2023: $8.7B2024: $8.2B2025: $9.2B2026: $9.8B20192026
Free cash flow$5.4B2026
$1.5B$3B$4.5B$6B2019: $5.9B2020: $6B2021: $4.9B2022: $6B2023: $4.6B2024: $5.2B2025: $5.2B2026: $5.4B20192026
EPS$3.732026
$0.93$1.87$2.8$3.732019: $3.412020: $3.542021: $2.662022: $3.732023: $2.822024: $2.762025: $3.612026: $3.7320192026
Cash / Debt$1.9B2026
$7.1B$14.3B$21.4B$28.5B2019 · Cash: $4.4B2019 · Debt: $25.3B2020 · Cash: $4.1B2020 · Debt: $24.8B2021 · Cash: $3.6B2021 · Debt: $26.4B2022 · Cash: $3.7B2022 · Debt: $24.1B2023 · Cash: $1.5B2023 · Debt: $24.4B2024 · Cash: $1.3B2024 · Debt: $25B2025 · Cash: $2.2B2025 · Debt: $28.5B2026 · Cash: $1.9B2026 · Debt: $28B20192026
CashDebt
Profitability+65.0%2026
+17.5%+35.0%+52.5%+70.0%2019 · Gross margin: +70.0%2020 · Gross margin: +67.4%2021 · Gross margin: +65.2%2022 · Gross margin: +68.0%2023 · Gross margin: +65.7%2024 · Gross margin: +65.3%2025 · Gross margin: +65.3%2026 · Gross margin: +65.0%2019 · Operating margin: +20.5%2020 · Operating margin: +16.6%2021 · Operating margin: +14.9%2022 · Operating margin: +18.2%2023 · Operating margin: +17.6%2024 · Operating margin: +15.9%2025 · Operating margin: +17.8%2026 · Operating margin: +17.8%2019 · Net margin: +15.2%2020 · Net margin: +16.6%2021 · Net margin: +12.0%2022 · Net margin: +15.9%2023 · Net margin: +12.0%2024 · Net margin: +11.4%2025 · Net margin: +13.9%2026 · Net margin: +13.2%20192026
Gross marginOperating marginNet margin
Revenue growth+8.4%2026
-1.9%+1.5%+5.0%+8.4%2020: -5.4%2021: +4.2%2022: +5.2%2023: -1.4%2024: +3.6%2025: +3.6%2026: +8.4%20192026
Shares outstanding1.3B2026
339.4M678.8M1B1.4B2019: 1.4B2020: 1.4B2021: 1.4B2022: 1.4B2023: 1.3B2024: 1.3B2025: 1.3B2026: 1.3B20192026
Valuation22.22026
12.224.436.648.92019 · P/E: 25.42020 · P/E: 27.82021 · P/E: 48.92022 · P/E: 27.82023 · P/E: 32.12024 · P/E: 28.82025 · P/E: 23.22026 · P/E: 22.22019 · P/S: 3.82020 · P/S: 4.62021 · P/S: 5.82022 · P/S: 4.42023 · P/S: 3.92024 · P/S: 3.32025 · P/S: 3.22026 · P/S: 2.920192026
P/EP/S

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20275.98$39.1B+7%15
FY 20286.39$40.3B+11%15
FY 20296.91$42.1B+16%6
FY 20307.50$44.7B+23%4
FY 20318.09$46B+26%3
Q3 20271.44$9.7B+7%7

Company events

6
2026-11-17EarningsActual - / Estimate 1.34-
2026-09-25Dividend$0.72-
2026-09-01Earnings · Before market openActual 1.45 / Estimate 1.39Beat
2026-06-26Dividend$0.72-
2026-06-03EarningsActual 1.55 / Estimate 1.54Beat
2026-03-27Dividend$0.71-

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
VRTX$129B10.229.3+34.9%3ISRG$139B12.644.4+28.4%8REGN$80.8B5.218.7+27.9%6PFE$157.3B2.536.5+6.8%3BSX$64.4B3.117.5+17.5%2MRNA$61.1B27.4-19.3-141.4%21GILD$186.4B6.1-57.7-10.6%7NVO$192B3.810.2+35.3%14

Analyst track record

How the analysts covering MDT have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings200539
Analysts3034
Buy / hold / sell133 / 67 / 0319 / 210 / 10
Upgrades / downgrades / initiations6 / 0 / 211 / 0 / 4
Price targets hit / missed25 / 148 (14%)119 / 330 (27%)
Avg. return after a rating (TipRanks)-11.8%-6.2%
Best / worst call+16.0% / -25.8%+36.4% / -25.8%

After buy calls on this stock: median 21-day move +1.9% vs S&P 500 -1.2% (n = 305)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Lee HambrightBernstein82% hit rate on this stock · 11 targets measuredBuytarget $97.00Jun 4, 2026
  2. Shagun Singh ChadhaRBC Capital75% hit rate on this stock · 12 targets measuredBuytarget $118Sep 1, 2026
  3. Anthony PetroneMizuho Securities70% hit rate on this stock · 10 targets measuredBuytarget $115Sep 2, 2026

Latest ratings

DateAnalystCallTarget
Sep 17, 2026Michael MatsonNeedhamBuyMaintained$114article ↗
Sep 15, 2026Josh JenningsTD CowenBuyReiterated$110article ↗
Sep 15, 2026Josh JenningsTD CowenBuyReiterated$110
Sep 14, 2026Travis SteedBank of America SecuritiesBuyMaintained$110article ↗
Sep 10, 2026Brandon VazquezWilliam BlairBuyMaintained–article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$80.00$90.00$100$110Oct 25 · Buy 12 · Hold 14 · Sell 1Oct 25Nov 25 · Buy 12 · Hold 13 · Sell 0Dec 25 · Buy 13 · Hold 13 · Sell 0Dec 25Jan 26 · Buy 15 · Hold 12 · Sell 0Feb 26 · Buy 14 · Hold 8 · Sell 0Feb 26Mar 26 · Buy 14 · Hold 9 · Sell 0Apr 26 · Buy 15 · Hold 11 · Sell 0Apr 26May 26 · Buy 14 · Hold 11 · Sell 0Jun 26 · Buy 14 · Hold 10 · Sell 0Jun 26Jul 26 · Buy 16 · Hold 9 · Sell 0Aug 26 · Buy 16 · Hold 8 · Sell 0Aug 26Sep 26 · Buy 17 · Hold 9 · Sell 0Oct 25 · avg. target $101Nov 25 · avg. target $110Dec 25 · avg. target $111Jan 26 · avg. target $112Feb 26 · avg. target $114Mar 26 · avg. target $113Apr 26 · avg. target $107May 26 · avg. target $106Jun 26 · avg. target $98.83Jul 26 · avg. target $97.74Aug 26 · avg. target $98.50Sep 26 · avg. target $104Oct 25 · month-end close $90.70Nov 25 · month-end close $105Dec 25 · month-end close $96.06Jan 26 · month-end close $103Feb 26 · month-end close $97.66Mar 26 · month-end close $86.65Apr 26 · month-end close $80.97May 26 · month-end close $73.81Jun 26 · month-end close $78.23Jul 26 · month-end close $85.39Aug 26 · month-end close $90.65Sep 26 · month-end close $92.77

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Sep 18, 2026 · 200 ratings